Windlas Biotech Limited (WINDLAS.BO)
INR 968.85
(0.09%)
INR 968.85
(0.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.3 Billion INR | 23.58% |
| 2022 | 5.1 Billion INR | 10.19% |
| 2021 | 4.63 Billion INR | 8.59% |
| 2020 | 4.26 Billion INR | 29.92% |
| 2019 | 3.28 Billion INR | 7.59% |
| 2018 | 3.05 Billion INR | -13.28% |
| 2017 | 3.51 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.75 Billion INR | 2.26% |
| 2023 Q2 | 1.52 Billion INR | 5.45% |
| 2023 Q3 | 1.62 Billion INR | 6.25% |
| 2023 FY | 6.3 Billion INR | 23.58% |
| 2023 Q1 | 1.44 Billion INR | 4.76% |
| 2023 Q4 | 1.71 Billion INR | 5.59% |
| 2022 Q2 | 1.32 Billion INR | 10.67% |
| 2022 FY | 5.1 Billion INR | 10.19% |
| 2022 Q4 | 1.38 Billion INR | 15.46% |
| 2022 Q3 | 1.19 Billion INR | -9.81% |
| 2022 Q1 | 1.19 Billion INR | 0.3% |
| 2021 Q4 | 1.19 Billion INR | 1.69% |
| 2021 FY | 4.63 Billion INR | 8.59% |
| 2021 Q3 | 1.17 Billion INR | 2.03% |
| 2021 Q2 | 1.15 Billion INR | 3.87% |
| 2021 Q1 | 1.1 Billion INR | 4.76% |
| 2020 Q4 | 1.05 Billion INR | -9.62% |
| 2020 Q3 | 1.17 Billion INR | 15.67% |
| 2020 Q1 | 1.02 Billion INR | 38.24% |
| 2020 Q2 | 1.01 Billion INR | -0.93% |
| 2020 FY | 4.26 Billion INR | 29.92% |
| 2019 FY | 3.28 Billion INR | 7.59% |
| 2019 Q4 | 739.84 Million INR | 0.0% |
| 2018 FY | 3.05 Billion INR | -13.28% |
| 2017 FY | 3.51 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alkem Laboratories Limited | 126.67 Billion INR | 95.019% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -49.789% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | 89.677% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | 51.297% |
| Aurobindo Pharma Limited | 287.04 Billion INR | 97.802% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -1475.999% |
| Eris Lifesciences Limited | 20.09 Billion INR | 68.596% |
| FDC Limited | 19.42 Billion INR | 67.526% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | 72.365% |
| Ipca Laboratories Limited | 76.22 Billion INR | 91.722% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -202.324% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -1151.363% |
| Laurus Labs Limited | 50.01 Billion INR | 87.385% |
| Lupin Limited | 200.1 Billion INR | 96.847% |
| Medicamen Biotech Limited | 1.79 Billion INR | -251.887% |
| Medico Remedies Limited | 1.44 Billion INR | -335.38% |
| Megasoft Limited | 373.95 Million INR | -1587.26% |
| NATCO Pharma Limited | 40.02 Billion INR | 84.234% |
| Piramal Pharma Limited | 81.71 Billion INR | 92.278% |
| Sigachi Industries Limited | 3.98 Billion INR | -58.152% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | 49.05% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 98.699% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | 39.986% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -143.383% |
| Themis Medicare Limited | 3.81 Billion INR | -65.275% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | 94.051% |
| Valiant Laboratories Limited | 1.82 Billion INR | -246.57% |
| Wanbury Limited | 5.75 Billion INR | -9.608% |
| ZIM Laboratories Limited | 3.67 Billion INR | -71.724% |
| Zydus Lifesciences Limited | 190.21 Billion INR | 96.683% |
| Ajanta Pharma Limited | 42.08 Billion INR | 85.008% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | 50.741% |
| Achyut Healthcare Limited | 61.36 Million INR | -10181.347% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -504.74% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -735.202% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | 65.246% |
| Alpa Laboratories Limited | 1.08 Billion INR | -480.248% |
| Gufic Biosciences Limited | 8.06 Billion INR | 21.782% |
| Ind-Swift Limited | 5.02 Billion INR | -25.571% |
| Indoco Remedies Limited | 17.89 Billion INR | 64.74% |
| Hester Biosciences Limited | 3.04 Billion INR | -107.179% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | 18.084% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -33.277% |
| RPG Life Sciences Limited | 5.82 Billion INR | -8.402% |
| Mankind Pharma Limited | 103.34 Billion INR | 93.895% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | 94.659% |
| Unichem Laboratories Limited | 16.57 Billion INR | 61.931% |
| Bal Pharma Limited | 3.39 Billion INR | -86.002% |
| Strides Pharma Science Limited | 40.51 Billion INR | 84.425% |
| Venus Remedies Limited | 5.91 Billion INR | -6.68% |
| Jubilant Pharmova Limited | 67.02 Billion INR | 90.587% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 97.74% |
| Divi's Laboratories Limited | 78.45 Billion INR | 91.957% |
| Nectar Lifesciences Limited | 16.84 Billion INR | 62.534% |
| Shilpa Medicare Limited | 11.51 Billion INR | 45.211% |
| Aarti Drugs Limited | 25.28 Billion INR | 75.047% |
| IOL Chemicals and Pharmaceuticals Limited | 21.18 Billion INR | 70.223% |
| Suven Life Sciences Limited | 116.92 Million INR | -5296.061% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.84 Billion INR | 81.891% |
| Hikal Limited | 17.84 Billion INR | 64.644% |
| Procter & Gamble Health Limited | 11.51 Billion INR | 45.194% |
| Sequent Scientific Limited | 13.69 Billion INR | 53.936% |
| Novartis India Limited | 3.35 Billion INR | -88.306% |
| Granules India Limited | 45.06 Billion INR | 85.999% |
| Wockhardt Limited | 27.89 Billion INR | 77.377% |
| Brooks Laboratories Limited | 794.86 Million INR | -693.794% |
| Neuland Laboratories Limited | 15.58 Billion INR | 59.517% |
| Morepen Laboratories Limited | 17.01 Billion INR | 62.926% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -308.723% |
| Mangalam Drugs & Organics Limited | 3.68 Billion INR | -71.179% |